Published in Addiction on November 01, 2012
RCT Comparing Methadone and Buprenorphine in Pregnant Women | NCT00271219
Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention. Drug Alcohol Depend (2013) 0.78
Infantile hypophosphatasia secondary to a novel compound heterozygous mutation presenting with pyridoxine-responsive seizures. JIMD Rep (2013) 0.77
Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone. Drug Alcohol Depend (2013) 0.76
Judging the Neonatal Abstinence Syndrome Assessment Tools to Guide Future Tool Development: The use of Clinimetrics as Opposed to Psychometrics. Front Pediatr (2017) 0.75
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev (2008) 4.74
Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med (2010) 3.84
Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch Gen Psychiatry (1978) 3.33
Buprenorphine: how to use it right. Drug Alcohol Depend (2003) 2.35
Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am (1998) 2.33
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend (2005) 2.26
Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict (2008) 2.17
Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction (2006) 2.04
Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution. Drug Alcohol Depend (2005) 1.90
Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther (1995) 1.73
The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag (2009) 1.70
Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs. Pediatrics (1998) 1.68
Substance use during pregnancy: time for policy to catch up with research. Harm Reduct J (2004) 1.67
The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics (2004) 1.61
Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend (2008) 1.57
The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend (2003) 1.54
Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction (2008) 1.51
Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J Clin Pharmacol Biopharm (1975) 1.49
Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study. Eur Addict Res (2009) 1.41
The relationship between maternal use of heroin and methadone and infant birth weight. Addiction (1997) 1.41
The narcotic-dependent mother: fetal and neonatal consequences. Early Hum Dev (1977) 1.40
Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther (2002) 1.40
Buprenorphine suppresses heroin use by heroin addicts. Science (1980) 1.27
Bidirectional transfer of methadone across human placenta. Biochem Pharmacol (2005) 1.19
Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther (1990) 1.14
Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned. Addiction (2012) 1.13
Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Neuro Endocrinol Lett (2008) 1.11
Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics (1985) 1.08
Clinical actions of fentanyl and buprenorphine. The significance of receptor binding. Br J Anaesth (1985) 0.99
Neonatal abstinence scores in opioid-exposed and nonexposed neonates: a blinded comparison. J Opioid Manag (2011) 0.94
Heroin epidemics revisited. Epidemiol Rev (1995) 0.94
Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice. J Pharm Sci (2009) 0.79
A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction (2006) 8.57
Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics (2002) 4.24
Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med (2010) 3.84
Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics (2012) 3.08
Delay discounting predicts postpartum relapse to cigarette smoking among pregnant women. Exp Clin Psychopharmacol (2007) 2.77
Clinical implications of reinforcement as a determinant of substance use disorders. Annu Rev Psychol (2004) 2.74
Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial. Exp Clin Psychopharmacol (2008) 2.68
Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Arch Gen Psychiatry (2005) 2.50
Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study. J Addict Med (2015) 2.38
A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. JAMA Psychiatry (2013) 2.29
A pilot study on voucher-based incentives to promote abstinence from cigarette smoking during pregnancy and postpartum. Nicotine Tob Res (2004) 2.23
Mild opioid deprivation increases the degree that opioid-dependent outpatients discount delayed heroin and money. Psychopharmacology (Berl) (2002) 2.23
Community reinforcement therapy for cocaine-dependent outpatients. Arch Gen Psychiatry (2003) 2.20
Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction (2008) 2.12
The occurrence of cannabis use disorders and other cannabis-related problems among first-year college students. Addict Behav (2007) 2.11
Distance traveled to outpatient drug treatment and client retention. J Subst Abuse Treat (2003) 1.86
Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. Addiction (2007) 1.83
Concurrent and retrospective reports of alcohol consumption across 30, 90 and 366 days: interactive voice response compared with the timeline follow back. J Stud Alcohol (2002) 1.78
Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat (2008) 1.77
Evidence of connective tissue involvement in acupuncture. FASEB J (2002) 1.75
Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction (2010) 1.71
Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol (2003) 1.70
Nonmedical Use of Prescription Stimulants and Analgesics: Associations with Social and Academic Behaviors among College Students. J Drug Issues (2008) 1.63
Dynamic fibroblast cytoskeletal response to subcutaneous tissue stretch ex vivo and in vivo. Am J Physiol Cell Physiol (2004) 1.60
Subcutaneous tissue fibroblast cytoskeletal remodeling induced by acupuncture: evidence for a mechanotransduction-based mechanism. J Cell Physiol (2006) 1.60
Maternal smoking and its association with birth weight. Obstet Gynecol (2005) 1.55
Uterine artery hemodynamic adaptations through the menstrual cycle into early pregnancy. Obstet Gynecol (2002) 1.54
Prevalence and predictors of persistent suicide ideation, plans, and attempts during college. J Affect Disord (2010) 1.54
Sociodemographic correlates of energy drink consumption with and without alcohol: results of a community survey. Addict Behav (2010) 1.50
Using interactive voice response to enhance brief alcohol intervention in primary care settings. J Stud Alcohol Drugs (2008) 1.49
Delay discounting in current and former marijuana-dependent individuals. Exp Clin Psychopharmacol (2010) 1.48
Biochemical verification of smoking status in pregnant and recently postpartum women. Exp Clin Psychopharmacol (2007) 1.45
Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics (2004) 1.44
Firesetting in adolescence and being aggressive, shy, and rejected by peers: new epidemiologic evidence from a national sample survey. J Am Acad Psychiatry Law (2003) 1.44
Financial incentives for smoking cessation among pregnant and newly postpartum women. Prev Med (2011) 1.44
Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Fetal Neonatal Med (2012) 1.43
Change in care among nonenrolled patients during and after a randomized trial. Pediatrics (2013) 1.42
Connective tissue fibroblast response to acupuncture: dose-dependent effect of bidirectional needle rotation. J Altern Complement Med (2007) 1.42
Tissue displacements during acupuncture using ultrasound elastography techniques. Ultrasound Med Biol (2004) 1.42
An experimental examination of the initial weeks of abstinence in cigarette smokers. Exp Clin Psychopharmacol (2004) 1.39
Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend (2003) 1.36
Educational disadvantage and cigarette smoking during pregnancy. Drug Alcohol Depend (2009) 1.32
Nonmedical use of prescription stimulants during college: four-year trends in exposure opportunity, use, motives, and sources. J Am Coll Health (2012) 1.32
Sharing and selling of prescription medications in a college student sample. J Clin Psychiatry (2010) 1.31
Decline in alcohol consumption during two years of daily reporting. J Stud Alcohol (2002) 1.28
Maintaining Superior Follow-Up Rates in a Longitudinal Study: Experiences from the College Life Study. Int J Mult Res Approaches (2012) 1.27
Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend (2004) 1.26
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction (2012) 1.25
Predictors of postpartum relapse to smoking. Drug Alcohol Depend (2007) 1.25
Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol (2013) 1.25
College students rarely seek help despite serious substance use problems. J Subst Abuse Treat (2009) 1.24
Smoking status in the initial weeks of quitting as a predictor of smoking-cessation outcomes in pregnant women. Drug Alcohol Depend (2006) 1.22
Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat (2006) 1.22
Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol (2010) 1.22
Brief intervention in alcohol-dependent versus nondependent individuals. J Stud Alcohol Drugs (2008) 1.21
Marijuana exposure opportunity and initiation during college: parent and peer influences. Prev Sci (2012) 1.20
Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. Pediatrics (2008) 1.18
Disruption of frontocerebellar circuitry and function in alcoholism. Alcohol Clin Exp Res (2003) 1.18
Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study. J Appl Behav Anal (2008) 1.17
Evidence for significant polydrug use among ecstasy-using college students. J Am Coll Health (2006) 1.17
A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes. Subst Abuse (2013) 1.16
Longitudinal brain metabolic characterization of chronic alcoholics with proton magnetic resonance spectroscopy. Alcohol Clin Exp Res (2002) 1.16
Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J (2009) 1.16
THE EFFECTS OF REDUCED CIGARETTE SMOKING ON DISCOUNTING FUTURE REWARDS: AN INITIAL EVALUATION. Psychol Rec (2008) 1.16
Effect of roasting on the formation of chlorogenic acid lactones in coffee. J Agric Food Chem (2005) 1.15
Response to Wouldes and Woodward: maternal methadone dose during pregnancy and infant clinical outcome. Neurotoxicol Teratol (2013) 1.15
Delay discounting is associated with treatment response among cocaine-dependent outpatients. Exp Clin Psychopharmacol (2011) 1.14